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To evaluate the efficacy of urinary neutrophil gelatinase-associated lipocalin (uNGAL) for
predicting the degree of acute kidney injury (AKI) in patients following partial nephrectomy
(PN).
Methods
This prospective study included 176 patients who underwent open or laparoscopic PN for
solid renal tumors between June 2013 and May 2014. Urine samples were collected preop-
eratively and at 3, 24, and 48 h after renal pedicle clamp removal. Changes in uNGAL levels
were analyzed for all patients and between subgroups that were dichotomized based on
preoperative eGFR values of <60 and60 mL/min/1.73m2, open and laparoscopic surgery,
and according to the onset of AKI. Linear mixed models were used to investigate preopera-
tive and perioperative features associated with postoperative uNGAL and eGFR changes at
6 months postoperatively.
Results
Among 146 patients included in the final analysis, 10 (6.8%) patients had preoperative
eGFR <60 mL/min/1.73m2. In the overall group, uNGAL levels increased following PN.
However, all subgroups demonstrated comparable changes in uNGAL levels over time.
Multivariate analyses failed to reveal any correctable clinical features associated with post-
operative uNGAL changes, whereas preoperative serum creatinine levels and the onset of
AKI correlated with eGFR at 6 months postoperatively.
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Conclusions
uNGAL levels may increase following PN. However, it does not appear to be a useful
marker for quantifying the degree of AKI or predicting postoperative renal function in
patients with normal contralateral kidney and relatively good preoperative renal function.
Further analysis is necessary to assess the usefulness of uNGAL in patients with poor pre-
operative renal function.
Introduction
The American Urological Association Guidelines recommend partial nephrectomy (PN) as the
treatment of choice for cT1 tumors, as PN has demonstrated to offer oncological control equal
to that of radical nephrectomy (RN), and at the same time, preserve renal function [1,2]. Not-
withstanding the advantages of PN with respect to renal function preservation, patients under-
going this procedure are prone to viable parenchymal loss and ischemic renal injury, with
subsequent risks for acute kidney injury (AKI) and chronic kidney disease. Many studies have
relied on serum creatinine (sCr) levels to objectively estimate the degree of AKI during PN and
to predict postoperative long-term renal function [3–5]. However, relatively small changes in
sCr levels compared to large and rapid changes in glomerular filtration rate (GFR) deter the
accurate diagnosis of AKI and may underestimate the degree of injury in the early phases of
AKI [6].
Previous studies have proposed neutrophil gelatinase-associated lipocalin (NGAL) as an
attractive marker for the early identification of ischemic and/or tubular damage [7–10], and
few representative studies have evaluated the usefulness of urinary NGAL (uNGAL) for quanti-
fying AKI following PN [11–13]. Abassi et al. reported the usefulness of uNGAL as a marker
for AKI following open PN and demonstrated its performance in quantifying the degree of
AKI [11]. In contrast, other studies have reported negative results for uNGAL in assessing AKI
in patients who underwent open PN [12,13]. However, these studies were limited by small
numbers of patients and the inclusion of only open procedures, wherein renal injury is mini-
mized by renal protective measures such as cold ischemia. Indeed, in the current era of mini-
mally invasive surgery, a large proportion of PN procedures are performed via laparoscopic or
robot-assisted approaches; in these settings, the risk of AKI increases owing to warm ischemia
and increased intraoperative abdominal pressure resulting from pneumoperitoneum.
To further investigate the efficacy of uNGAL in quantifying AKI during and subsequent to
PN, we assessed a relatively large cohort of patients for changes in uNGAL following open or
laparoscopic PN and the clinical features associated with these changes. In order to assess renal
functional changes in these patients, we also evaluated whether changes in uNGAL levels fol-




This study was approved by the Institutional Ethics Committee of Yonsei University College of
Medicine, after review of the protocol and procedures employed (4-2013-0261), with all sam-
ples collected after obtaining informed consent prior to PN. All patients provided written con-
sent to participate in the current study.
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2.2. Patients
Urine and serum samples were prospectively collected in 176 consecutive patients who under-
went PN at a single institution for single, solid, and enhancing renal tumors between June 2013
and May 2014. All patients exhibited a well-enhancing contralateral kidney evidenced by pre-
operative computed tomography (CT). PN was performed as previously described using an
open or laparoscopic approach according to the surgeons’ preference [14,15]. Ischemia type
(none, warm, or cold) and the use of intravenous mannitol were decided according to surgeon
discretion and depending on each intraoperative situation. For each patient, the clinical fea-
tures were prospectively recorded, including sex; age; body mass index (BMI); presence of co-
morbidities, namely, diabetes mellitus and cardiovascular disease (CVD); preoperative sCr;
preoperative aspects and dimensions used for an anatomical (PADUA) score of renal tumors;
estimated blood loss (EBL); ischemia type; and ischemia time. CVD was defined as the pres-
ence of preoperative coronary artery disease, heart failure, hypertension, high cholesterol levels,
hyperlipidemia, and/or high triglyceride levels. AKI was defined as an increase of sCr of more
than 50% or by 0.3 mg% from the baseline within 48 h of surgical insult [16].
2.3. Sample collection
Urine samples were collected preoperatively via a urethral Foley catheter inserted after the
induction of general anesthesia and at 3, 24, and 48 h after renal pedicle clamp removal. In
patients operated without renal pedicle clamping, samples were collected 3, 24, and 48 h after
the termination of renorrhaphy. Collected urine samples were immediately transported to the
clinical laboratory, where they were stored at -80°C until analysis. Samples were later analyzed
for NGAL (R&D systems, Abingdon, UK) and Cr (Roche Diagnostics GmbH, Mannheim, Ger-
many) using commercially available enzyme-linked immunosorbent assays. Serum sample
analyses were performed as part of routine clinical practice.
2.4. Statistical analysis
Baseline characteristics of the patients were compared using descriptive statistical tests between
the open and laparoscopic PN groups. Appropriate comparative tests, e.g., Student’s t-test and
χ2-test, were used to compare continuous and categorical variables. Clinical factors including
the AKI rate were also compared between groups with preoperative eGFR<60 and60 mL/
min/1.73 m2 using descriptive statistical tests such as Student’s t-test or χ2-test.
To evaluate changes in uNGAL levels following PN between groups with differing postoper-
ative renal function, linear mixed models were used to measure uNGAL changes by time peri-
ods for the overall group and according to each clinical subgroup, namely, preoperative eGFR
<60 and60 mL/min/1.73 m2, open and laparoscopic groups, and groups with and without
AKI. All analyses were performed together for absolute values and percent changes from base-
line of postoperative uNGAL and normalized uNGAL (the ratio of uNGAL to urine creati-
nine), with adjustment for preoperative values. Normalized uNGAL was used to avoid the
potential dilution effect of uNGAL due to hydration status and the use of intravenous
mannitol.
Univariate linear mixed models were used to identify clinical factors—namely, age, sex,
BMI, preoperative eGFR, preoperative normalized uNGAL, presence of diabetes and CVD,
EBL, AKI, PADUA score, differences in surgical type and ischemia type, ischemia time, and
use of mannitol—that were associated with changes in uNGAL and normalized uNGAL, with
adjustment for preoperative values.
Univariate linear regression analyses were performed to identify clinical predictors, includ-
ing the above-mentioned clinical factors and postoperative uNGAL changes, associated with
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eGFR changes at 6 months postoperatively, with adjustment for preoperative eGFR values. All
tests were two-sided, with statistical significance set at p< 0.05. Statistical analyses were per-
formed using SAS version 9.2 (SAS Institute Inc., Cary, NC, USA).
Results
3.1. Clinical features
Of the 176 patients, we obtained adequate specimens from 146 (82.9%) patients for incorpo-
ration in the final analysis. Patients’ characteristics are presented in Table 1. There were no sig-
nificant differences between the open and laparoscopic groups, except that laparoscopic PN
was more frequently performed with warm ischemia as compared to open PN. Overall, the 10
patients with preoperative eGFR<60 mL/min/1.73 m2 were older (median age 65 vs. 54 years,
p< 0.001) and had a higher incidence of CVD (70% vs. 37%, p = 0.040) than those with eGFR
60 mL/min/1.73 m2. However, there were no differences in sex, BMI, the incidence of diabe-
tes, ischemia type, or the incidence of AKI between the two groups (data not presented).
Table 1. Patient characteristics of patients treated with partial nephrectomy via open or laparoscopic approach.
Open Laparoscopic p
No. 76 70
Age 54.5 ± 11.9 52.4 ± 12.9 0.314
Sex 0.276
Male 48 (63.2%) 38 (54.3%)
Female 28 (36.8%) 32 (45.7%)
Body mass index (kg/m2) 24.8 ± 3.4 24.3 ± 2.8 0.379
Diabetes 8 (10.5%) 10 (14.3%) 0.490
Cardiovascular disease 34 (44.7%) 23 (32.9%) 0.142
uNGAL (ng/ml)
Preoperative 8.02 ± 12.3 6.50 ± 10.2 0.419
Preoperative normalized 7.20 ± 15.3 5.79 ± 7.5 0.490
Preoperative sCr (mg/dl) 0.86 ± 0.03 0.84 ± 0.02 0.516
Preoperative eGFR 80.3 ± 12.4 82.9 ± 9.1 0.151
AKI 20 (26.3%) 14 (20.0%) 0.367
Ischemia type <0.001
Cold 22 (29.0%) 0 (0%)
Warm 46 (60.5%) 60 (85.7%)
None 8 (10.5%) 10 (14.3%)
Ischemia time (min) 20.1 ± 9.9 22.9 ± 13.7 0.157
Estimated blood loss 211.8 ± 267.1 231.7 ± 198.5 0.613
Mannitol use 18 (23.7%) 20 (28.6%) 0.501
PADUA score 0.165
6–7 37 (48.7%) 26 (37.1%)
8–9 35 (46.1%) 35 (50.0%)
10 4 (5.2%) 9 (12.9%)
Data are number (%) and mean ± S.D.
AKI = acute kidney injury
eGFR = estimated glomerular ﬁltration rate
PADUA = preoperative aspects and dimensions used for an anatomical
sCr = serum creatinine
uNGAL = urinary neutrophil gelatinase-associated lipocalin
doi:10.1371/journal.pone.0133675.t001
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3.2. Changes in uNGAL and normalized uNGAL following PN
As depicted in Fig 1, postoperative uNGAL and normalized uNGAL were increased in
the overall group (β = 0.51, 95% CI 0.36–0.66, p< 0.001 and β = 0.41, 95% CI 0.18–0.65,
p< 0.001, respectively). However, as presented in Fig 2, subgroup analyses revealed no signifi-
cant differences in the changes in uNGAL and normalized uNGAL over time between the sub-
groups with preoperative eGFR<60 and60 mL/min/1.73 m2 (uNGAL: β = -0.42, 95% CI
-0.97 –-0.12, p = 0.128 and normalized uNGAL: β = -0.54, 95% CI -1.40–0.33, p = 0.220),
between the open and laparoscopic groups (uNGAL: β = 0.12, 95% CI -0.19–0.42, p = 0.451
and normalized uNGAL: β = -0.16, 95% CI -0.65–0.32, p = 0.509), and between the groups
with AKI and without AKI (uNGAL: β = -0.18, 95% CI -0.53–0.18, p = 0.339 and normalized
uNGAL: β = -0.30, 95% CI -0.87–0.27, p = 0.308). Given the variations in baseline uNGAL and
normalized uNGAL levels, we further analyzed these values in respect to percent changes from
Fig 1. Levels of (A) uNGAL and (B) normalized uNGAL, shown by time periods in the overall group following partial nephrectomy (n = 146).
doi:10.1371/journal.pone.0133675.g001
Fig 2. Levels of uNGAL (A, B, and C) and normalized uNGAL (D, E, and F) shown by time periods between subgroups following partial
nephrectomy.
doi:10.1371/journal.pone.0133675.g002
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baseline. However, there were no significant differences in percent changes in uNGAL levels
between all subgroups (data not shown).
3.3. Predictors of postoperative uNGAL
After adjusting for preoperative uNGAL, univariate linear mixed models demonstrated preop-
erative normalized uNGAL to be associated with an increase in postoperative uNGAL (β =
0.85, 95% CI 0.78–0.92, p< 0.001). No association was observed between the incidences of dia-
betes, CVD, or AKI; EBL; PADUA score; surgery type; ischemia type; ischemia time; or manni-
tol use with changes in postoperative uNGAL (Table 2).
3.4. Predictors of postoperative eGFR at 6 months postoperatively
For 90 patients who were observed until postoperative 6 months, univariate linear regression
models were used to evaluate clinical factors indicative of eGFR at postoperative 6 months. Pre-
operative sCr level was associated with decreased eGFR (β = -16.503, 95% CI -28.457 –-4.549,
Table 2. Univariate linear mixedmodels for predicting postoperative uNGAL, adjusted for preoperative uNGAL.
NGAL Normalized uNGAL
β (95% CI)* p β (95% CI)* p
Age -0.059 (-0.208, 0.09) 0.437 0.041 (-0.096, 0.178) 0.556
Sex
Male Reference Reference
Female -1.497 (-5.24, 2.246) 0.431 -1.127 (-4.576, 2.322) 0.519
Body mass index -0.123 (-0.713, 0.467) 0.681 -0.208 (-0.751, 0.335) 0.449
Preoperative eGFR -0.009 (-0.177, 0.159) 0.917 -0.016 (-0.171, 0.139) 0.835
Preoperative normalized uNGAL 0.849 (0.778, 0.921) <0.001 -1.244 (-6.425, 3.937) 0.636
Diabetes -3.272 (-8.862, 2.317) 0.249 0.531 (-2.953, 4.014) 0.764
Cardiovascular disease 0.186 (-3.596, 3.969) 0.923 -0.003 (-0.01, 0.004) 0.393
Estimated blood loss -0.002 (-0.01, 0.006) 0.602 0.008 (-4.012, 4.027) 0.997
AKI 2.39 (-1.958, 6.739) 0.279 2.387 (-1.151, 5.924) 0.185
PADUA score
6–7 Reference Reference
8–9 3.091 (-0.75, 6.933) 0.114 2.387 (-1.151, 5.924) 0.185
10 4.702 (-2.037, 11.44) 0.170 -2.724 (-8.924, 3.477) 0.387
Surgery type
Open Reference Reference
Laparoscopic -1.127 (-4.816, 2.562) 0.547 -1.912 (-5.297, 1.474) 0.266
Ischemia
None Reference Reference
Cold -1.636 (-8.746, 5.475) 0.650 -2.766 (-9.288, 3.757) 0.403
Warm -0.879 (-6.582, 4.824) 0.761 0.04 (-5.193, 5.273) 0.988
Ischemia
None Reference Reference
Warm or cold -1.019 (-6.632, 4.595) 0.720 -0.44 (-5.612, 4.733) 0.867
Ischemia time -0.038 (-0.192, 0.117) 0.633 -0.061 (-0.203, 0.082) 0.403
Mannitol use -2.756 (-6.937, 1.426) 0.195 -1.833 (-5.694, 2.027) 0.349
*Estimated change in postoperative uNGAL per unit of predictor
Abbreviations as in Table 1
doi:10.1371/journal.pone.0133675.t002
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p = 0.007) at 6 months postoperatively. The onset of AKI was also associated with a decrease of
8.73 mL/min/1.73 m2 (β = -8.73, 95% CI -12.69 –-4.77, p< 0.001) in eGFR at 6 months postop-
eratively. The uNGAL level at 3 h after renal pedicle clamp removal was associated with an
increased eGFR (β = 0.07, 95% CI 0.01–0.13, p = 0.023) at 6 months postoperatively. However,
no significant association existed between normalized uNGAL level at 3 h and eGFR at 6
months postoperatively (β = 0.038, 95% CI -0.002–0.077, p = 0.060; Table 3).
Discussion
To date, there have been no objective clinical predictors for quantifying the degree of AKI and
long-term renal function; until recently, NGAL has been reported as a useful marker for the
Table 3. Univariate linear regressionmodels for predicting eGFR at postoperative 6 months.
β (95% CI)* p
Age -0.098 (-0.262, 0.066) 0.237
Sex
Male Reference
Female 2.112 (-1.607, 5.831) 0.262
Body mass index -0.254 (-0.914, 0.406) 0.447
Diabetes 1.440 (-5.016, 7.895) 0.659
Cardiovascular disease -2.785 (-6.903, 1.332) 0.182
Estimated blood loss -0.002 (-0.009, 0.006) 0.693
Preoperative sCr -16.503 (-28.457, -4.549) 0.007
AKI -8.731 (-12.69, -4.766) <0.001
PADUA score
6–7 Reference
8–9 -0.064 (-3.818, 3.689) 0.973
10 -5.411 (-12.37, 1.548) 0.126
Surgery type
Open Reference
Laparoscopic -0.249 (-3.957, 3.459) 0.894
Ischemia
None Reference
Cold -3.171 (-10.37, 4.030) 0.384
Warm -1.063 (-7.574, 5.448) 0.746
Ischemia
None Reference
Warm or cold -1.630 (-8.020, 4.761) 0.614
Ischemia time -0.071 (-0.231, 0.090) 0.388
Mannitol use -1.862 (-5.895, 2.170) 0.361
uNGAL postoperative 3hr 0.072 (0.010, 0.133) 0.023
uNGAL postoperative 24hr 0.018 (-0.102, 0.137) 0.770
uNGAL postoperative 48hr 0.019 (-0.038, 0.076) 0.505
Normalized uNGAL postoperative 3hr 0.038 (-0.002, 0.077) 0.060
Normalized uNGAL postoperative 24hr 0.066 (-0.016, 0.147) 0.110
Normalized uNGAL postoperative 48hr 0.045 (-0.002, 0.092) 0.060
*Estimated change in postoperative eGFR per unit of predictor
Abbreviations as in Table 1.
doi:10.1371/journal.pone.0133675.t003
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early identification of ischemic and/or tubular damage [10,17–22]. However, not many human
studies have documented the efficacy of NGAL in quantifying AKI following PN in patients
with normal contralateral kidney. Two studies that have incorporated patients who underwent
open PN have reported conflicting results. Initial results reported by Abassi et al. demonstrated
uNGAL as a quantitative marker for AKI based on the results of 27 patients who underwent
open PN [11]. In contrast, Sprenkle et al. showed negative results for the usefulness of uNGAL
since they observed that the levels of uNGAL after open PN were comparable to those after
thoracic surgery [12]. Unfortunately, both studies are limited by a relatively small number of
patients and the inclusion of only open PN, wherein most surgeries were performed with the
use of maximal renal protective techniques. Therefore, these observations may be due to mini-
mal renal damage rather than the inability of uNGAL to determine the degree of renal injury.
In this study that comprised a relatively large cohort of open and laparoscopic PN cases, we
addressed whether the level of uNGAL altered significantly after PN and whether it could be
utilized as a quantitative marker for AKI after PN.
We postulated that if the change in NGAL level is a useful marker for quantifying AKI after
PN, there would be a difference between subgroups. Accordingly, we analyzed changes in
uNGAL levels according to time periods following PN between various subgroups, namely,
patients with preoperative eGFR<60 and60 mL/min/1.73 m2, open and laparoscopic PN,
and patients with and without AKI. We also reviewed whether clinical factors and uNGAL
changes were associated with eGFR changes at 6 months postoperatively, assuming that if
uNGAL were a useful marker for AKI after PN, it would eventually reflect long-term renal
function.
In the present study, only 6.8% of patients had preoperative eGFR<60 mL/min/1.73 m2;
therefore, the uNGAL changes over time following PN in our overall patients were considered
likely to represent postoperative uNGAL changes in the unilateral renal injury model in
patients with normal contralateral kidney and relatively good preoperative renal function. We
observed increased uNGAL levels over time following PN in the entire patient cohort; however,
the uNGAL changes over time did not differ among the subgroups, those who may have differ-
ent postoperative renal function. Notably, there were no differences in the postoperative
uNGAL changes between patients who underwent open and laparoscopic PNs, probably due
to comparable clinical confounders between the two groups, except for the type of ischemia.
Our findings did not agree with previous findings as we failed to demonstrate any differences
in the uNGAL changes over time between groups with preoperative eGFR<60 and60 mL/
min/1.73 m2 (40% vs. 22%, p = 0.240) [12]. Moreover, uNGAL changes over time did not show
any differences even between the groups with and without AKI.
The negative results for uNGAL as a marker of AKI between the clinical subgroups were in
accordance with previous results, which failed to identify any clinical factors associated with
the levels of uNGAL [12]. In our study, only preoperative normalized uNGAL was associated
with an increase in postoperative uNGAL level (β = 0.85). Moreover, preoperative sCr level
and the presence of AKI were both associated with decreases in the postoperative 6-month
eGFR, rather than a change in uNGAL itself. Unexpectedly, the level of uNGAL at 3 h follow-
ing renal pedicle clamp removal was associated with the level of eGFR at 6 months postopera-
tively. Although this finding was counterintuitive, its clinical usefulness seems to be limited as
evidenced by the low β value of 0.07, and the observation that normalized uNGAL level at 3 h
was not associated with an increased eGFR at 6 months postoperatively. The linear regression
analysis for predicting eGFR at postoperative 6 months was performed for only 90 patients
who were followed until postoperative 6 months, and the postoperative follow-up period itself
seemed to be relatively short to assess long-term renal function. Indeed, studies with a larger
Urinary NGAL as a Marker of Kidney Injury
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cohort of patients with at least 1 year follow-up period is warranted to clearly evaluate clinical
factors indicative of long-term renal function.
Based on these results, we suggest that an increase in uNGAL may not reflect the degree of
AKI severity or postoperative renal function in patients with a normal contralateral kidney and
a relatively good preoperative renal function. Moreover, unlike previous studies, our results
may be applied to not only PN but also to ureteroscopic or shockwave lithotripsy procedures
and in other unilateral renal injury models in healthy patients [23]. Parekh et al. also reported
that the changes of several urinary biomarkers for AKI, including uNGAL, were relatively
small and were not associated with the extent of structural alteration during ischemia, duration
of ischemia, or the transient increases of creatinine in patients undergoing PN. They suggested
that the lesser discriminative power of the biomarkers in patients with PN may be caused by
the lack of more severe and sustained injury by surgical procedures, and that urinary biomark-
ers may not be useful for predicting early functional AKI in this setting [13].
The current study has certain limitations. First, our results are in accordance with those of
Sprenkle et al., wherein uNGAL did not appear to be a useful marker for detecting renal injury
in healthy patients treated by PN [12]. However, we did not observe any differences between
groups with preoperative eGFR<60 and60 mL/min/1.73 m2 in terms of the incidence of
AKI and changes in uNGAL levels at different time points. This discrepancy may arise from
the limited number of patients (6.8%) with preoperative eGFR<60 mL/min/1.73 m2 in our
study. Further studies with a larger cohort of patients with poor preoperative renal function are
in need to evaluate the clinical usefulness of uNGAL. Second, we collected all urine samples
through a urethral Foley catheter for convenience and timed-collection of preoperative and
postoperative urine samples. However, the change of intravascular volume or blood pressure
levels following the induction of general anesthesia may have influenced the baseline levels of
uNGAL. For these reasons, a comprehensive analysis was performed for both postoperative
uNGAL and normalized uNGAL in an effort to overcome such potential bias. Moreover, urine
samples were collected through a Foley catheter, and therefore, uNGAL levels may have been
underestimated due to the urine volume excreted from the normal contralateral kidney. The
uNGAL level in the urine sample collected through a ureteral catheter from the ipsilateral kid-
ney undergoing partial nephrectomy may hold greater clinical relevance for AKI severity.
However, a useful clinical marker should be easily applicable in routine clinical practice; there-
fore, we evaluated the usefulness of uNGAL levels in urine samples obtained from the urethral
catheter. Third, the postoperative follow-up period of 6 months was relatively short for assess-
ing long-term renal function. Moreover, we were unable to incorporate the relative volume of
preserved, vascularized renal tissue into our predictive models, while this factor has been sug-
gested to predict postoperative renal function [24]. Lastly, our study included a prospectively
collected, larger cohort of PN cases as compared to previous studies. Nevertheless, variations in
baseline patient features, namely, eGFR (preoperative eGFR<60 and60 mL/min/1.73 m2),
comorbidity, age, tumor complexity, surgical factors (open versus laparoscopic, use of manni-
tol, ischemia time and type, and surgeon experience), and the limited number of patients in
each subgroup, is a clear limitation. For a better understanding of the clinical usefulness of
uNGAL, further studies with a stricter inclusion criterion, preferably with a larger number of
patients will be needed.
Conclusions
While uNGAL levels may increase after PN, the changes in uNGAL levels did not differ among
the subgroups that may exhibit different postoperative renal function. Therefore, we suggest
that the usefulness of uNGAL for quantifying AKI severity and predicting postoperative renal
Urinary NGAL as a Marker of Kidney Injury
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function is limited in patients with normal contralateral kidney and relatively good preopera-
tive renal function.
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